Peptonic receives approximately SEK 49.9 thousand through warrants of series TO5
Reading Time: 3 minutes NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, CANADA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE
#24-400 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Audientes A/S: Q3 2024 Financial Report
Reading Time: 4 minutes Company announcement no. 33-2024November 21, 2024 Audientes A/S (“Audientes” or the “Company”), CVR 36047631, announces its unaudited financial results for Q3 2024. The Company provides updates on progress in its key markets and adjusts its sales and financial objectives for the
Fondia Plc: Share repurchase 21.11.2024
Reading Time: < 1 minute Fondia Plc Company release 21.11.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 21.11.2024 Fondia Plc First North Finland Date 21.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 323 Average price/share, EUR 5,90
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 21.11.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024 Date 21.11.2024 Exchange transaction Buy Share class ALEX Amount 210 Average price/share 8.6500 EUR Highest
Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion
Reading Time: 2 minutes Oslo, November 21st 2024: Lytix Biopharma refers to the release made today by its licensing partner Verrica Pharmaceuticals, announcing the pricing of a USD 42 million underwritten public offering. The offering is expected to close on November 22, 2024, and the
Biosergen Releases Interview with Principal Investigator Dr. Pawan Singh on Drug-Resistant Fungal Infections and BSG005
Reading Time: 2 minutes November 21, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, is pleased to announce the release of a fireside-chat-style video interview during the World Antimicrobial Resistance Awareness Week (WAAW). The video features the company’s CEO,
Monitra Health Announces Grant of U.S. Patent for Advanced Wireless Cardiac Monitoring Technology
Reading Time: 3 minutes Monitra Healthcare Private Limited, a pioneer in health monitoring technologies, proudly announces the grant of its U.S. Patent No. 12,109,029 B2, titled Wireless Cardiac Monitoring Device and Method to Measure and Transmit Cardiac Physiological Signals. This patent, issued by the United States Patent and Trademark
Arkion Wins Contract with Elvia, Norway’s Largest Distribution Grid Operator
Reading Time: 2 minutes Stockholm, Sweden – Oslo, Norway – November 21, 2024 – Arkion, a leading provider of AI-powered asset analytics, proudly announces its selection as the sole provider of detailed condition assessments for Elvia. Elvia, one of Norway’s largest electricity networks, has
Royalti Achieves an Unprecedented 200 Crores Sales at Oberoi Garden City Launch
Reading Time: 2 minutes Royalti, a distinguished real estate consulting firm in the high-end and luxury market has set a new benchmark by grossing over Rs. 200 crores in sales at the recent launch of Oberoi Garden City (OGC) on Pokhran Road 2, Thane. This exceptional achievement, recorded within